Imagine spending years developing a promising new treatment, only to have its potential clouded by something as simple (and as overlooked) as whether or not people actually took their pills. This isn’t just a small glitch in the process. In … Read More
clinical trials
Medication adherence VS compliance: what’s the difference and why it matters
You’ll often hear the terms “adherence” and “compliance” used as if they mean the same thing. But in healthcare and clinical research, they carry very different meanings. Understanding that difference can change the way we work with patients, design better … Read More
AARDEX Group and Pill Connect Partner to Advance Dose Selection with Real-Time Adherence Monitoring in Phase 2A Clinical Trial
Liège, Belgium and Manchester, UK; August 2025: AARDEX Group, a global leader in digital medication adherence solutions, and Pill Connect, a pioneer in connected dispensing technology, have announced a strategic partnership to support a multi-cohort Phase 2A dose selection trial. … Read More
What is medication adherence and why does it matter in clinical trials?
Medication adherence is an element of successful clinical research. It refers to the degree to which a patient follows a prescribed medication regimen including when and how often the medication is taken, and whether it is discontinued prematurely. In clinical … Read More
In pursuit of better answers: WHO aims for higher quality clinical trial evidence with best-practice guidance
WHO cares. It’s now time you did Why Change is Needed in Clinical Trials? The old adage tells us not to fix things that aren’t broken. Logic suggests, therefore, that whenever a fix is being applied, things aren’t working as … Read More
WHO Cares: A pro-adherence strategy means little without the drive for better data quality
Enhancing Adherence in Clinical Trials: A Strategic Imperative When a high-profile authority in the medical world, such as the World Health Organization (WHO), publishes guidelines on best practices in clinical trials, the industry takes note. Aiming for Reform and Improvement … Read More
From Sealed Envelopes to Smart Adherence: Why Clinical Trials Must Embrace Digital Innovation
Introduction: The Role of Innovation in Clinical Trials Nostalgia can trick us into thinking that things were better in the “good old days”. But the world of science is rarely a place where sentimentality should cloud better judgement. Rather, it … Read More
Protecting your investment: How clinical trial failings are costing the investor community
When bringing a new drug product to market, powerful motivating forces are involved. And while the potential for enhancing, or even extending, the lives of patients unquestionably takes primacy, there is another inescapably influential factor in the mix: profitability. For … Read More
Drug dose reduction’s role in tackling Pharma 2.0’s profitability problem
The economic model that has underpinned the development of drug products for decades is currently under siege. Faced on one side with mounting pressure from payers to address affordability issues, pharmaceutical companies are facing ever more stringent regulatory requirements alongside … Read More
One size fails all? The weight of evidence for personalized dosing in oral GLP-1 therapies
The Rise of GLP-1 Therapies In recent years, the pharmaceutical industry has borne witness to the meteoric rise of glucagon-like peptide-1 receptor agonist (GLP-1) therapies. Having fast become established as a potentially life-changing treatment for Type 2 diabetes and obesity, emerging … Read More